Holen Sie sich die Stockscreener-App
23.27
2.39%
-0.57
Handel nachbörslich:
23.26
-0.010
-0.04%
Schlusskurs vom Vortag:
$23.84
Offen:
$23.37
24-Stunden-Volumen:
639.67K
Relative Volume:
0.86
Marktkapitalisierung:
$2.88B
Einnahmen:
$1.80B
Nettoeinkommen (Verlust:
$15.62M
KGV:
193.92
EPS:
0.12
Netto-Cashflow:
$118.36M
1W Leistung:
-2.02%
1M Leistung:
+5.82%
6M Leistung:
-0.04%
1J Leistung:
-7.88%
1-Tages-Spanne:
$22.83
$23.58
1-Wochen-Bereich:
$22.48
$24.61
52-Wochen-Spanne:
$18.77
$26.51
Privia Health Group Inc Stock (PRVA) Company Profile
Firmenname
Privia Health Group Inc
Sektor
Branche
Telefon
571-366-8850
Adresse
950 N. GLEBE RD., SUITE 700, ARLINGTON
Compare PRVA vs VEEV, TEM, BTSG, HQY, WAY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRVA
Privia Health Group Inc
|
23.27 | 2.95B | 1.80B | 15.62M | 118.36M | 0.12 |
|
VEEV
Veeva Systems Inc
|
195.49 | 32.23B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
52.26 | 9.48B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
41.49 | 8.08B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
78.36 | 6.83B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
25.71 | 5.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-01-10 | Eingeleitet | Needham | Buy |
| 2024-12-16 | Eingeleitet | Macquarie | Outperform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-22 | Eingeleitet | Citigroup | Buy |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Fortgesetzt | Jefferies | Buy |
| 2024-02-22 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-06-13 | Eingeleitet | Evercore ISI | Outperform |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2023-03-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-02-03 | Eingeleitet | Goldman | Buy |
| 2022-12-09 | Eingeleitet | Stifel | Buy |
| 2022-12-08 | Eingeleitet | UBS | Buy |
| 2022-09-07 | Fortgesetzt | Truist | Buy |
| 2022-05-03 | Eingeleitet | BofA Securities | Buy |
| 2022-04-28 | Eingeleitet | BTIG Research | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2022-02-22 | Hochstufung | Cowen | Market Perform → Outperform |
| 2022-01-03 | Eingeleitet | Jefferies | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-05-24 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-05-24 | Eingeleitet | Credit Suisse | Outperform |
| 2021-05-24 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-24 | Eingeleitet | Piper Sandler | Overweight |
| 2021-05-24 | Eingeleitet | Truist | Buy |
| 2021-05-24 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Privia Health Group Inc Aktie (PRVA) Neueste Nachrichten
Is Privia Health Group (PRVA) Priced Attractive After Recent Share Price Swings - simplywall.st
Privia Health Soars 9.98% to Hit Intraday High of $25.16 - Markets Mojo
Privia Health Earnings Call Highlights Growth And Cash - TipRanks
PRVA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Breaking Down Privia Health Gr: 5 Analysts Share Their Views - Benzinga
Citigroup Issues Pessimistic Forecast for Privia Health Group (NASDAQ:PRVA) Stock Price - MarketBeat
Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration - marketscreener.com
Privia Health price target raised to $33 from $31 at Truist - Yahoo Finance
Royce & Associates LP Buys 214,166 Shares of Privia Health Group, Inc. $PRVA - MarketBeat
Matthew Shawn Morris Sells 16,550 Shares of Privia Health Group (NASDAQ:PRVA) Stock - MarketBeat
Matthew Shawn Morris Sells 7,788 Shares of Privia Health Group (NASDAQ:PRVA) Stock - MarketBeat
Privia Health Group (NASDAQ:PRVA) CFO David Mountcastle Sells 7,697 Shares - MarketBeat
Privia Health Group (NASDAQ:PRVA) CFO David Mountcastle Sells 5,361 Shares - MarketBeat
Privia Health Group Insider Sold Shares Worth $326,835, According to a Recent SEC Filing - marketscreener.com
Privia Health (PRVA) director sells 24,338 shares after option exercise - Stock Titan
Privia (NASDAQ: PRVA) CFO sells 13,058 shares via 10b5-1 plan - Stock Titan
PRVA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Privia Health Group (NASDAQ:PRVA) Stock Price Expected to Rise, Truist Financial Analyst Says - MarketBeat
Truist Adjusts Price Target on Privia Health to $33 From $31, Maintains Buy Rating - marketscreener.com
Jefferies Maintains Buy on PRVA Privia Health Group, Inc. Feb 2026 - Meyka
Privia Health Group (PRVA) Is Up 8.0% After Earnings Beat And Higher 2026 Revenue Outlook – Has The Bull Case Changed? - simplywall.st
Privia Health Expands Value Based Care Scale With Evolent ACO Acquisition - Yahoo Finance
Privia Health Group (PRVA) Is Up 8.0% After Raising 2026 Revenue Guidance and Beating Q4 Targets - Yahoo Finance
Privia Health Gr (PRVA) Receives Buy Rating with Increased Price Target | PRVA Stock News - GuruFocus
Decoding Privia Health Group Inc (PRVA): A Strategic SWOT Insigh - GuruFocus
PRVA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Privia Health, Repligen, and RadNet Shares Plummet, What You Need To Know - The Globe and Mail
Privia Health Group (PRVA) Margin Expansion To 1.1% Tests High P E Narrative - simplywall.st
Canaccord Genuity Group Issues Positive Forecast for Privia Health Group (NASDAQ:PRVA) Stock Price - MarketBeat
Wall Street Analysts Think Privia Health (PRVA) Could Surge 25.45%: Read This Before Placing a Bet - sharewise.com
Privia Health Group, Inc. (NASDAQ:PRVA) Q4 2025 Earnings Call Transcript - Insider Monkey
Privia Health Group, Inc. SEC 10-K Report - TradingView
Privia Health (Nasdaq: PRVA) expands value-based care footprint - Stock Titan
Privia Health Group Q4 Earnings Call Highlights - MarketBeat
Privia Health Group (NASDAQ:PRVA) Issues Earnings Results - MarketBeat
Piper Sandler raises Privia Health stock price target on strong results By Investing.com - Investing.com South Africa
Privia Health: Q4 Earnings Snapshot - theheraldreview.com
Earnings Call Summary | Privia Health(PRVA.US) Q4 2025 Earnings Conference - 富途牛牛
Jefferies raises Privia Health stock price target on strong quarter - Investing.com South Africa
Jefferies raises Privia Health stock price target on strong quarter By Investing.com - Investing.com India
Insider sale notice: 23,887 shares sold (NASDAQ: PRVA) - Stock Titan
Piper Sandler raises Privia Health stock price target on strong results - Investing.com India
Privia Health Group, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:PRVA) 2026-02-26 - Seeking Alpha
Privia Health Group, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Privia Health Group Breaks Above 200-Day Moving AverageBullish for PRVA - Nasdaq
Privia Health Q4 2025 slides: EBITDA surges 39%, guidance strong - Investing.com
Privia Health Group (NASDAQ:PRVA) Stock Price Up 9.4% Following Earnings Beat - MarketBeat
Privia Health (PRVA) Q4 2025 Earnings Transcript - The Globe and Mail
Privia Health Q4 2025 slides: EBITDA surges 39%, guidance strong By Investing.com - Investing.com South Africa
Earnings call transcript: Privia Health Q4 2025 earnings soar past expectations - Investing.com Nigeria
Privia Health Group Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Finanzdaten der Privia Health Group Inc-Aktie (PRVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Privia Health Group Inc-Aktie (PRVA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Morris Matthew Shawn | Director |
Feb 26 '26 |
Option Exercise |
2.00 |
7,788 |
15,576 |
75,976 |
| Morris Matthew Shawn | Director |
Feb 27 '26 |
Sale |
25.00 |
16,550 |
413,750 |
68,188 |
| Morris Matthew Shawn | Director |
Feb 26 '26 |
Sale |
24.99 |
7,788 |
194,622 |
68,188 |
| Mountcastle David | EVP & Chief Financial Officer |
Feb 27 '26 |
Option Exercise |
2.00 |
7,697 |
15,394 |
180,606 |
| Mountcastle David | EVP & Chief Financial Officer |
Feb 26 '26 |
Option Exercise |
2.00 |
5,361 |
10,722 |
178,270 |
| Mountcastle David | EVP & Chief Financial Officer |
Feb 27 '26 |
Sale |
25.05 |
7,697 |
192,810 |
172,909 |
| Mountcastle David | EVP & Chief Financial Officer |
Feb 26 '26 |
Sale |
25.00 |
5,361 |
134,025 |
172,909 |
3.84%
0.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):